Valproic acid
Depakene, Stavzor (valproic acid) is a small molecule pharmaceutical. Valproic acid was first approved as Depakene on 1982-01-01. It is used to treat absence epilepsy, alzheimer disease, bipolar disorder, complex partial epilepsy, and epilepsy amongst others in the USA. It is known to target histone deacetylase 1.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
valproic acid | ANDA | 2023-03-30 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
absence epilepsy | HP_0011147 | D004832 | G40.A |
alzheimer disease | EFO_0000249 | D000544 | F03 |
bipolar disorder | EFO_0000289 | D001714 | F30.9 |
complex partial epilepsy | EFO_1000877 | D017029 | — |
epilepsy | EFO_0000474 | D004827 | G40.9 |
mood disorders | EFO_0004247 | D019964 | F30-F39 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
28 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ischemic stroke | D000083242 | — | 1 | 2 | — | 2 | 5 | ||
Ischemia | D007511 | EFO_0000556 | — | 1 | 2 | — | — | 3 | |
Diabetic foot | D017719 | EFO_1001459 | — | 1 | 2 | — | — | 3 | |
Stroke | D020521 | EFO_0000712 | I63.9 | — | 1 | 1 | — | — | 2 |
Arterial occlusive diseases | D001157 | EFO_0009085 | — | 1 | 1 | — | — | 2 | |
Empyema | D004653 | EFO_0003097 | 1 | — | 1 | — | — | 2 | |
Infections | D007239 | EFO_0000544 | — | — | 1 | — | — | 1 | |
Hemothorax | D006491 | J94.2 | — | — | 1 | — | — | 1 | |
Pneumonia | D011014 | EFO_0003106 | J18 | — | — | 1 | — | — | 1 |
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Venous thrombosis | D020246 | HP_0004936 | I82.40 | — | — | — | — | 1 | 1 |
Covid-19 | D000086382 | U07.1 | — | — | — | — | 1 | 1 | |
Subarachnoid hemorrhage | D013345 | EFO_0000713 | I60 | — | — | — | — | 1 | 1 |
Intracranial vasospasm | D020301 | EFO_1000994 | G45.9 | — | — | — | — | 1 | 1 |
Hydrocephalus | D006849 | HP_0000238 | G91 | — | — | — | — | 1 | 1 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | — | — | — | 1 | 1 |
Vascular access devices | D062666 | — | — | — | — | 1 | 1 | ||
Mortality | D009026 | EFO_0004352 | — | — | — | — | 1 | 1 | |
Abdominal pain | D015746 | R10.9 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | VALPROIC ACID |
INN | valproic acid |
Description | Valproic acid is a branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem. It has a role as an anticonvulsant, a GABA agent, an EC 3.5.1.98 (histone deacetylase) inhibitor, a teratogenic agent, a psychotropic drug, a neuroprotective agent and an antimanic drug. It is a branched-chain saturated fatty acid and a branched-chain fatty acid. It is functionally related to a valeric acid. It is a conjugate acid of a valproate. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCCC(CCC)C(=O)O |
Identifiers
PDB | — |
CAS-ID | 99-66-1 |
RxCUI | 11118 |
ChEMBL ID | CHEMBL109 |
ChEBI ID | 39867 |
PubChem CID | 3121 |
DrugBank | DB00313 |
UNII ID | 614OI1Z5WI (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
HDAC1
HDAC1
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 31,359 documents
View more details
Safety
Black-box Warning
Black-box warning for: Valproic acid
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
97 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more